Skip to main content

Wingrove Theresa's Form 4 filing

ImmunoGen, Inc. (IMGN) · filed Dec 1, 2023

Accession no.
0001415889-23-015711
Filed
Dec 1, 2023
Trade date
Nov 29-30, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $4.87M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Wingrove TheresaCIK 0001510720Officer (SVP OF REGULATORY AFFAIRS)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 29, 2023Common StockMOption exerciseAcquired+6,792$10.65+$72,334.89,603Direct
Nov 29, 2023Common StockSSaleDisposed−6,792$16.66−$113,154.722,811Direct
Nov 30, 2023Common StockMOption exerciseAcquired+133,691$10.65+$1,423,809.15136,502Direct
Nov 30, 2023Common StockMOption exerciseAcquired+30,733$10.79+$331,609.07167,235Direct
Nov 30, 2023Common StockSSaleDisposed−164,424$28.95−$4,760,074.82,811Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 29, 2023Common StockMOption exerciseDisposed−6,792$0.00$0133,691Direct
Nov 30, 2023Common StockMOption exerciseDisposed−133,691$0.00$00Direct
Nov 30, 2023Common StockMOption exerciseDisposed−30,733$0.00$09,267Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)